| Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial T Powles, M Kockx, A Rodriguez-Vida, I Duran, SJ Crabb, ... Nature medicine 25 (11), 1706-1714, 2019 | 492 | 2019 |
| International consensus guidelines for scoring the histopathological growth patterns of liver metastasis PJ Van Dam, EP Van Der Stok, LA Teuwen, GG Van den Eynden, ... British journal of cancer 117 (10), 1427-1441, 2017 | 197 | 2017 |
| TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer B De Laere, S Oeyen, M Mayrhofer, T Whitington, PJ van Dam, ... Clinical cancer research 25 (6), 1766-1773, 2019 | 145 | 2019 |
| Comprehensive profiling of the androgen receptor in liquid biopsies from castration-resistant prostate cancer reveals novel intra-AR structural variation and splice variant … B De Laere, PJ van Dam, T Whitington, M Mayrhofer, EH Diaz, ... European urology 72 (2), 192-200, 2017 | 137 | 2017 |
| Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling SJ Van Laere, GG Van den Eynden, I Van der Auwera, M Vandenberghe, ... Breast cancer research and treatment 95, 243-255, 2006 | 136 | 2006 |
| Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis M Mayrhofer, B De Laere, T Whitington, P Van Oyen, C Ghysel, J Ampe, ... Genome medicine 10, 1-13, 2018 | 124 | 2018 |
| Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node GG Van den Eynden, MK Vandenberghe, PJH van Dam, CG Colpaert, ... Clinical cancer research 13 (18), 5391-5397, 2007 | 121 | 2007 |
| Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder B Szabados, M Kockx, ZJ Assaf, PJ van Dam, A Rodriguez-Vida, I Duran, ... European Urology 82 (2), 212-222, 2022 | 81 | 2022 |
| Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes DJE Peeters, PJ Van Dam, GGM Van den Eynden, A Rutten, H Wuyts, ... British journal of cancer 110 (2), 375-383, 2014 | 80 | 2014 |
| Are costs of robot‐assisted surgery warranted for gynecological procedures? P Van Dam, J Hauspy, L Verkinderen, XB Trinh, PJ Van Dam, L Van Looy, ... Obstetrics and Gynecology International 2011 (1), 973830, 2011 | 63 | 2011 |
| A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV … Y Jansen, V Kruse, J Corthals, K Schats, PJ van Dam, T Seremet, ... Cancer Immunology, Immunotherapy 69, 2589-2598, 2020 | 57 | 2020 |
| Replacement and desmoplastic histopathological growth patterns: a pilot study of prediction of outcome in patients with uveal melanoma liver metastases R Barnhill, P Vermeulen, S Daelemans, PJ van Dam, S Roman‐Roman, ... The Journal of Pathology: Clinical Research 4 (4), 227-240, 2018 | 55 | 2018 |
| Histopathological growth patterns as a candidate biomarker for immunomodulatory therapy PJ van Dam, S Daelemans, E Ross, Y Waumans, S Van Laere, E Latacz, ... Seminars in cancer biology 52, 86-93, 2018 | 50 | 2018 |
| Sentinel node detection in patients with vaginal carcinoma P van Dam, H Sonnemans, PJ van Dam, L Verkinderen, LY Dirix Gynecologic oncology 92 (1), 89-92, 2004 | 39 | 2004 |
| Time trends (2006–2015) of quality indicators in EUSOMA-certified breast centres PA Van Dam, M Tomatis, L Marotti, J Heil, RE Mansel, MR Del Turco, ... European Journal of Cancer 85, 15-22, 2017 | 37 | 2017 |
| Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value R Barnhill, PJ van Dam, P Vermeulen, G Champenois, A Nicolas, ... The Journal of Pathology: Clinical Research 6 (3), 195-206, 2020 | 36 | 2020 |
| Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancer DJE Peeters, GG Van den Eynden, PJ Van Dam, A Prové, IH Benoy, ... British journal of cancer 104 (9), 1472-1477, 2011 | 31 | 2011 |
| Circulating tumor cells and survival in abiraterone‐and enzalutamide‐treated patients with castration‐resistant prostate cancer B De Laere, S Oeyen, P Van Oyen, C Ghysel, J Ampe, P Ost, W Demey, ... The Prostate 78 (6), 435-445, 2018 | 28 | 2018 |
| Can medical imaging identify the histopathological growth patterns of liver metastases? E Latacz, PJ Van Dam, C Vanhove, L Llado, B Descamps, N Ruiz, I Joye, ... Seminars in Cancer Biology 71, 33-41, 2021 | 27 | 2021 |
| A comprehensive analysis of baseline clinical characteristics and biomarkers associated with outcome in advanced melanoma patients treated with pembrolizumab G Awada, Y Jansen, JK Schwarze, J Tijtgat, L Hellinckx, O Gondry, ... Cancers 13 (2), 168, 2021 | 27 | 2021 |
Luc Dirix在 telenet.be 的电子邮件经过验证
